Tramadol controlled release - e-Therapeutics

Drug Profile

Tramadol controlled release - e-Therapeutics

Alternative Names: ETS-6103; ETX6103; Tramadol extended release - e-Therapeutics; Tramadol hydrochloride; Tramadol sustained release - e-Therapeutics; Viotra

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator e-Therapeutics
  • Class Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Phenyl ethers; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Major depressive disorder

Most Recent Events

  • 22 Mar 2016 e-Therapeutics completes a phase IIb trial for Major depressive disorder in the United Kingdom (NCT02014363) prior to March 2016
  • 08 Mar 2016 Biomarkers information updated
  • 07 Jan 2016 Tramadol controlled release - e-Therapeutics is available for licensing as of 07 Jan 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top